BioTuesdays

Author - Leonard Zehr

Cellectar Biosciences Logo
Developments

Cellectar gets NCI grant for PDC platform

Cellectar Biosciences (NASDAQ:CLRB) has received initial notice of award for a Phase I-II Fast-Track Small Business Innovation Research (SBIR) grant. The SBIR grant provides up to $2.3-million over 2 1/2 years from the...

October 1, 2015
Feature

In conversation with Gagan Gill

By Len Zehr As CEO of closely-held SIGMA Surgical, an upstart data-analytics company, Gagan Gill has a passion for entrepreneurial adventure and startup culture. After stints in sales and marketing in the medical...

September 29, 2015
ANI Pharmaceuticals
Markets

Roth upgrades ANI Pharma to buy

Roth Capital Partners has upgraded ANI Pharmaceuticals (NASDAQ:ANIP) to ”buy” from “neutral” but lowered its price target to $60 from $67. The stock closed at $43.21 on Friday. “We are upgrading shares of ANI...

September 28, 2015
Vital Therapies
Developments

Vital outlines plans for new Phase 3 ELAD trial

Vital Therapies (NASDAQ:VTL) has outlined plans for a possible new Phase 3 clinical trial designed to confirm ELAD’s safety and efficacy in alcohol-induced liver decompensation (AILD), including severe acute alcoholic...

September 28, 2015
novadaq
Developments

Novadaq unveils SPY-Q Case Manager software

Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has unveiled its SPY-Q Case Manager (SPY-QCM) software at the Symposium on Advanced Wound Care Fall 2015 meeting in Las Vegas. SPY-QCM is an image acquisition and analysis...

September 28, 2015
Dipexium Pharmaceuticals
Developments

Dipexium presents Locilex data at ICAAC/ICC

Dipexium Pharmaceuticals and research collaborators, JMI Laboratories, have presented new Locilex microbiology data at the American Society for Microbiology’s Interscience Conference of Antimicrobial Agents and...

September 21, 2015